We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-0.76%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11.4B
AUM Growth
+$282M
Cap. Flow
+$504M
Cap. Flow %
4.41%
Top 10 Hldgs %
13.8%
Holding
2,664
New
339
Increased
765
Reduced
639
Closed
146

Sector Composition

Rank Sector Weight
1 Technology 15.18%
2 Healthcare 13.66%
3 Industrials 12.88%
4 Financials 10.57%
5 Energy 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONY icon
626
Sony
SONY
$129B
$1.22M 0.01%
338,300
+38,500
+13% +$139K
WOR icon
627
Worthington Enterprises
WOR
$2.82B
$1.22M 0.01%
53,210
+9,943
+23% +$247K
AZO icon
628
AutoZone
AZO
$49.3B
$1.21M 0.01%
2,376
-38
-2% -$20K
EEP
629
DELISTED
Enbridge Energy Partners
EEP
$1.2M 0.01%
30,873
PFS icon
630
Provident Financial Services
PFS
$3.13B
$1.19M 0.01%
72,605
+1,320
+2% +$22.3K
NJR icon
631
New Jersey Resources
NJR
$6.05B
$1.18M 0.01%
46,944
+36,560
+352% +$962K
RDS.B
632
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.18M 0.01%
14,940
+2,006
+16% +$169K
RVTY icon
633
Revvity
RVTY
$12.3B
$1.18M 0.01%
27,076
+112
+0.4% +$5.1K
FULT icon
634
Fulton Financial
FULT
$4.73B
$1.17M 0.01%
106,094
+5,615
+6% +$65.2K
ETR icon
635
Entergy
ETR
$53.9B
$1.17M 0.01%
30,350
+27,624
+1,013% +$1.05M
COR
636
DELISTED
Coresite Realty Corporation
COR
$1.16M 0.01%
35,360
BMRN icon
637
BioMarin Pharmaceuticals
BMRN
$11.7B
$1.16M 0.01%
16,100
IRM icon
638
Iron Mountain
IRM
$37.7B
$1.15M 0.01%
+35,160
New +$1.14M
ACOR
639
DELISTED
Acorda Therapeutics
ACOR
$1.14M 0.01%
+282
New +$1.06M
PL
640
DELISTED
PROTECTIVE LIFE CORP
PL
$1.14M 0.01%
16,487
+466
+3% +$32.4K
CVGI icon
641
Commercial Vehicle Group
CVGI
$162M
$1.14M 0.01%
184,700
-1,500
-0.8% -$13.2K
XLV icon
642
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$1.14M 0.01%
17,843
+1,437
+9% +$90K
NEU icon
643
NewMarket
NEU
$7.18B
$1.12M 0.01%
2,954
-116
-4% -$46K
SABA
644
DELISTED
SABA SOFTWARE INC
SABA
$1.12M 0.01%
82,943
+11,213
+16% +$151K
ALTO icon
645
Alto Ingredients
ALTO
$351M
$1.12M 0.01%
80,000
COF icon
646
Capital One
COF
$127B
$1.12M 0.01%
13,693
+7,110
+108% +$581K
CME icon
647
CME Group
CME
$91.9B
$1.11M 0.01%
13,958
+12,805
+1,111% +$965K
BBVA icon
648
Banco Bilbao Vizcaya Argentaria
BBVA
$146B
$1.11M 0.01%
97,343
-44,670
-31% -$521K
SGNT
649
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.11M 0.01%
35,680
URBN icon
650
Urban Outfitters
URBN
$6.13B
$1.11M 0.01%
30,215
+28,920
+2,233% +$1.06M

Similar funds

Glenmede Trust's Q3 2014 Portfolio in Review

As of Q3 2014, Glenmede Trust held 2,664 positions worth $11.4B, up 2.5% from $11.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $504M of net new capital in Q3 2014, opening 339 new positions and adding to 765 existing holdings. Its largest new stake was Acadia Healthcare: 426,301 shares worth $20.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Spirit Airlines, Inc., an estimated $22.2M trimmed.

  • Glenmede Trust's largest Q3 2014 buy was Acadia Healthcare: 426,301 shares worth $20.7M.
  • Glenmede Trust added most to Brunswick in Q3 2014, an estimated $24.1M increase.
  • Glenmede Trust's biggest Q3 2014 reduction was Spirit Airlines, Inc., cutting an estimated $22.2M.
  • Glenmede Trust fully exited Unisys in Q3 2014, selling an estimated $13.5M.
  • Glenmede Trust's ten largest holdings make up 14% of its $11.4B portfolio in Q3 2014.
  • Glenmede Trust opened 339 new positions and closed 146 in Q3 2014.
  • Glenmede Trust's portfolio value rose 2.5% quarter-over-quarter to $11.4B.

Based on Glenmede Trust's 13F filing for Q3 2014, filed 14 Nov 2014.